US 11384355
Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
granted A61PA61P1/16A61P31/00
Quick answer
US patent 11384355 (Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P1/16, A61P31/00